Literature DB >> 20624330

Why we need more debate on whether psychotic symptoms lie on a continuum with normality.

A S David1.   

Abstract

The notion that psychotic symptoms lie on a continuum with normality has become an accepted dogma. It is supported by several lines of empirical evidence, fits in with the orientation of modern services and has a 'moral' appeal. However, there is confusion as to the nature of the continuum or continua under discussion. According to the author, commentators on this topic do not often distinguish between the variability and severity of the phenomena themselves, within or between individuals, versus the distribution of symptoms or risk factors in a population. The implications of these two types of continua differ. Furthermore, the evidence for continua of delusional beliefs and hallucinations can be challenged on a number of grounds, both methodological and conceptual. To some extent, whether phenomena are viewed as continua or categories depends on the intentions of the observer. Finding the distinctive characteristics of psychotic phenomena in people with clinical disorders, in addition to their origins in 'normal' cognitive processes, is a worthwhile goal.

Entities:  

Mesh:

Year:  2010        PMID: 20624330     DOI: 10.1017/S0033291710000188

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  39 in total

1.  Reward System Dysfunction as a Neural Substrate of Symptom Expression Across the General Population and Patients With Schizophrenia.

Authors:  Joe J Simon; Sheila A Cordeiro; Marc-André Weber; Hans-Christoph Friederich; Robert C Wolf; Matthias Weisbrod; Stefan Kaiser
Journal:  Schizophr Bull       Date:  2015-05-25       Impact factor: 9.306

Review 2.  Cognition and brain function in schizotypy: a selective review.

Authors:  Ulrich Ettinger; Christine Mohr; Diane C Gooding; Alex S Cohen; Alexander Rapp; Corinna Haenschel; Sohee Park
Journal:  Schizophr Bull       Date:  2015-03       Impact factor: 9.306

3.  Auditory Hallucinations: Does a Continuum of Severity Entail Continuity in Mechanism?

Authors:  Flavie Waters; Charles Fernyhough
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

4.  An evolutionary perspective on paranoia.

Authors:  Nichola J Raihani; Vaughan Bell
Journal:  Nat Hum Behav       Date:  2018-12-17

5.  Perspective-taking abilities in the balance between autism tendencies and psychosis proneness.

Authors:  Ahmad M Abu-Akel; Stephen J Wood; Peter C Hansen; Ian A Apperly
Journal:  Proc Biol Sci       Date:  2015-06-07       Impact factor: 5.349

6.  RDoCs redux.

Authors:  Daniel R Weinberger; Terry E Goldberg
Journal:  World Psychiatry       Date:  2014-02       Impact factor: 49.548

7.  Psychosis as a continuous phenotype in the general population: the thin line between normality and pathology.

Authors:  Anthony S David; Olesya Ajnakina
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

8.  Variation in psychosocial influences according to the dimensions and content of children's unusual experiences: potential routes for the development of targeted interventions.

Authors:  Tamatha Ruffell; Matilda Azis; Nedah Hassanali; Catherine Ames; Sophie Browning; Karen Bracegirdle; Richard Corrigall; Kristin R Laurens; Colette Hirsch; Elizabeth Kuipers; Lucy Maddox; Suzanne Jolley
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-07-07       Impact factor: 4.785

9.  A Perceptual Inference Mechanism for Hallucinations Linked to Striatal Dopamine.

Authors:  Clifford M Cassidy; Peter D Balsam; Jodi J Weinstein; Rachel J Rosengard; Mark Slifstein; Nathaniel D Daw; Anissa Abi-Dargham; Guillermo Horga
Journal:  Curr Biol       Date:  2018-02-02       Impact factor: 10.834

10.  Relationships of perceived public stigma of mental illness and psychosis-like experiences in a non-clinical population sample.

Authors:  Yin-Ju Lien; Yu-Chen Kao; Yia-Ping Liu; Hsin-An Chang; Nian-Sheng Tzeng; Chien-Wen Lu; Shwu-Jon Lin; Ching-Hui Loh
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-07-23       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.